Evidence map›Paper›PMID 30066201›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

Palliative care and psychosocial care in metastatic non-small cell lung cancer: factors affecting utilisation of services and impact on patient survival.

Kirsten J Duggan, Jennifer Wiltshire, Rebecca Strutt, Miriam M Boxer, Angela Berthelsen, Joseph Descallar, Shalini K Vinod

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kirsten J DugganSouth West Sydney Local Health District Clinical Cancer Registry, Liverpool, NSW, Australia. kirsten.duggan@health.nsw.gov.au.ORCID http://orcid.org/0000-0002-5464-5125
Jennifer WiltshireDepartment of Palliative Care, South Western Sydney Local Health District, Liverpool, NSW, Australia.
Rebecca StruttDepartment of Palliative Care, South Western Sydney Local Health District, Liverpool, NSW, Australia.
Miriam M BoxerCancer Therapy Centre, South Western Sydney Local Health District, Liverpool, NSW, Australia.
Angela BerthelsenSouth West Sydney Local Health District Clinical Cancer Registry, Liverpool, NSW, Australia.
Joseph DescallarIngham Institute for Applied Medical Research, Liverpool, NSW, Australia.
Shalini K VinodCancer Therapy Centre, South Western Sydney Local Health District, Liverpool, NSW, Australia.
UNSW Sydney · AUIngham Institute · AUSouth Western Sydney Local Health District · AUSydney Local Health District · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPalliative care (PC) and psychosocial care (PSC) are essential services, which can positively impact on quality of life in patients with metastatic lung cancer, when advanced disease and poor prognosis preclude the use of curative therapies. The aims of this study were to describe patterns of PC and PSC and identify factors associated with service utilisation and overall patient survival.

methodA retrospective Australian cohort of South Western Sydney residents with newly diagnosed stage IV non-small cell lung cancer (NSCLC) in 2006-2012 was identified from the Local Health District Clinical Cancer Registry. Supplemental information was sourced from the area PC database and hospital medical records. Cox regression models with robust variance identified factors associated with PC and PSC and examined patient survival.

resultsA total of 923 patients were identified. Eighty-three per cent of patients were seen by PC, with 67% seen within 8 weeks of diagnosis. PSC utilisation was 82%. Radiotherapy treatment and residential area were associated with both PC and PSC. Increasing age was associated with early PC referral. Median overall survival was 4 months. PC was associated with patient survival; however, the effect varied over time.

conclusionThe rate of PC and PSC in our metastatic NSCLC population was high when compared with published data. Despite this, there were gaps in PC and PSC provision in this population, notably with patients not receiving active treatment, and those receiving systemic therapy utilising these services less frequently. PSC and PC contact were not convincingly associated with improved patient survival.

Indexed as

AdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungFacilities and Services UtilizationFemaleHospice and Palliative Care NursingHumansLung NeoplasmsMaleMiddle AgedNew South WalesPalliative CarePatient Acceptance of Health CareQuality of LifeRegistriesLung neoplasmsPalliative carePsychosocial careService utilisationSurvival

Identifiers

PMID30066201
OpenAlexW2887914097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.